Lompat ke isi

Lamotrigin: Perbedaan antara revisi

Dari Wikipedia bahasa Indonesia, ensiklopedia bebas
Jelajahi riwayat secara interaktif
Revisi selanjutnya →
Konten dihapus Konten ditambahkan
VisualTeks wiki
WanaraLima (bicara | kontrib)
1.694 suntingan
Dibuat dengan menerjemahkan halaman "User:Mr. Ibrahem/Lamotrigine"
 
WanaraLima (bicara | kontrib)
1.694 suntingan
Artikel baru tentang topik farmasi yang masih memerlukan tambahan dan pengembangan. Artikel ini merupakan terjemahan wikipedia bahasa Inggris masih perlu ditinjau ulang juga disesuaikan dengan padanan bahasa Indonesia
Baris 1: Baris 1:
{{Infobox drug
{{Infobox drug|drug_name=|image=|width=150px|alt=|image2=|width2=150px|alt2=|caption=|type=<!-- empty -->
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 420280917
| drug_name =
| INN =
| image =
| width = 150px
| alt =
| image2 =
| width2 = 150px
| alt2 =
| caption =
| imageL = Lamotrigine.svg
| widthL =
| altL =
| imageR = Lamotrigine ball-and-stick model.png
| widthR =
| altR =


| type = <!-- empty -->
<!-- Names -->|tradename=Lamictal, others<ref name=brands>{{cite web|title=Lamotrigine|url=https://www.drugs.com/international/lamotrigine.html|website=Drugs.com|access-date=9 December 2017|archive-date=10 December 2017|archive-url=https://web.archive.org/web/20171210072144/https://www.drugs.com/international/lamotrigine.html|url-status=live}}</ref>|synonyms=BW-430C; BW430C; 3,5-Diamino-6-(2,3-dichlorophenyl)-1,2,4-triazine|IUPAC_name=6-(2,3-dichlorophenyl)-1,2,4-triazine-3,5-diamine


<!-- Names -->
<!-- Clinical data -->|pregnancy_AU=D|pregnancy_US=C|pregnancy_category=|routes_of_administration=[[Oral administration|By mouth]]|duration_of_action=|dependency_liability=|Drugs.com={{drugs.com|monograph|lamotrigine}}|MedlinePlus=a695007
| pronounce = {{IPAc-en|l|ə|ˈ|m|oʊ|t|r|ᵻ|ˌ|dʒ|iː|n}}
| tradename = Lamictal, others<ref name=brands>{{cite web|title=Lamotrigine|url=https://www.drugs.com/international/lamotrigine.html|website=Drugs.com|access-date=9 December 2017|archive-date=10 December 2017|archive-url=https://web.archive.org/web/20171210072144/https://www.drugs.com/international/lamotrigine.html|url-status=live}}</ref>
| synonyms = BW-430C; BW430C; 3,5-Diamino-6-(2,3-dichlorophenyl)-1,2,4-triazine
| INN =
| IUPAC_name = 6-(2,3-dichlorophenyl)-1,2,4-triazine-3,5-diamine


<!-- Clinical data -->
<!-- Legal data -->|legal_AU=S4|legal_CA=Rx-only|legal_UK=POM|legal_US=Rx-only|legal_status=<!--For countries not listed above-->|DailyMedID=Lamotrigine|licence_US=Lamotrigine|licence_EU=<!-- EMA uses INN (or special INN_EMA) -->
| class = [[Anticonvulsant]]<ref name=AHFS2017>{{cite web|title=Lamotrigine|url=https://www.drugs.com/monograph/lamotrigine.html|publisher=The American Society of Health-System Pharmacists|access-date=8 December 2017|archive-date=10 December 2017|archive-url=https://web.archive.org/web/20171210020403/https://www.drugs.com/monograph/lamotrigine.html|url-status=live}}</ref>
| uses = [[Epilepsy]], [[bipolar disorder]]<ref name=AHFS2017>{{cite web|title=Lamotrigine|url=https://www.drugs.com/monograph/lamotrigine.html|publisher=The American Society of Health-System Pharmacists|access-date=8 December 2017|archive-date=10 December 2017|archive-url=https://web.archive.org/web/20171210020403/https://www.drugs.com/monograph/lamotrigine.html|url-status=live}}</ref>
| side_effects = Sleepiness, headache, vomiting, trouble with coordination, rash<ref name=AHFS2017>{{cite web|title=Lamotrigine|url=https://www.drugs.com/monograph/lamotrigine.html|publisher=The American Society of Health-System Pharmacists|access-date=8 December 2017|archive-date=10 December 2017|archive-url=https://web.archive.org/web/20171210020403/https://www.drugs.com/monograph/lamotrigine.html|url-status=live}}</ref>
| interactions = <!-- notable interactions -->
| pregnancy_AU = D
| pregnancy_AU_comment= <ref name="Drugs.com pregnancy">{{cite web | title=Lamotrigine Use During Pregnancy | website=Drugs.com | date=8 October 2019 | url=https://www.drugs.com/pregnancy/lamotrigine.html | access-date=24 March 2020 | archive-date=25 January 2021 | archive-url=https://web.archive.org/web/20210125224408/https://www.drugs.com/pregnancy/lamotrigine.html | url-status=live }}</ref>
| pregnancy_US = C
| pregnancy_US_comment= <ref name="Drugs.com pregnancy">{{cite web | title=Lamotrigine Use During Pregnancy | website=Drugs.com | date=8 October 2019 | url=https://www.drugs.com/pregnancy/lamotrigine.html | access-date=24 March 2020 | archive-date=25 January 2021 | archive-url=https://web.archive.org/web/20210125224408/https://www.drugs.com/pregnancy/lamotrigine.html | url-status=live }}</ref>
| pregnancy_category=
| breastfeeding =
| routes_of_administration= [[Oral administration|By mouth]]
| onset =
| duration_of_action=
| defined_daily_dose=
| typical_dose =
| dependency_liability=
| addiction_liability=


<!-- External links -->
<!-- Pharmacokinetic data -->|bioavailability=98%|protein_bound=55%|metabolism=[[Liver]] (mostly [[UGT1A4]]-mediated)|metabolites=|elimination_half-life=29 hours|excretion=[[Urine]] (65%), [[feces]] (2%)
| Drugs.com = {{drugs.com|monograph|lamotrigine}}
| MedlinePlus = a695007


<!-- Legal data -->
<!-- Chemical and physical data -->|C=9|Cl=2|H=7|N=5|smiles=NC1=NC(N)=NN=C1C2=CC=CC(Cl)=C2Cl|StdInChI=1S/C9H7Cl2N5/c10-5-3-1-2-4(6(5)11)7-8(12)14-9(13)16-15-7/h1-3H,(H4,12,13,14,16)|StdInChI_Ref={{stdinchicite|correct|chemspider}}|StdInChI_comment=|StdInChIKey=PYZRQGJRPPTADH-UHFFFAOYSA-N|StdInChIKey_Ref={{stdinchicite|correct|chemspider}}|molecular_weight=256.091|density=|melting_point=|melting_high=|melting_notes=|boiling_point=|boiling_notes=|solubility=|specific_rotation=}}
| legal_AU = S4
| legal_AU_comment =
| legal_BR = <!-- OTC, A1, A2, A3, B1, B2, C1, C2, C3, C4, C5, D1, D2, E, F-->
| legal_BR_comment =
| legal_CA = Rx-only
| legal_CA_comment =
| legal_DE = <!-- Anlage I, II, III or Unscheduled-->
| legal_DE_comment =
| legal_NZ = <!-- Class A, B, C -->
| legal_NZ_comment =
| legal_UN = <!-- N I, II, III, IV / P I, II, III, IV-->
| legal_UN_comment =
| legal_UK = POM
| legal_UK_comment =
| legal_US = Rx-only
| legal_US_comment =
| legal_status = <!--For countries not listed above-->
| DailyMedID = Lamotrigine
| licence_US = Lamotrigine
| licence_CA = <!-- Health Canada may use generic or brand name (generic name preferred) -->
| licence_EU = <!-- EMA uses INN (or special INN_EMA) -->


<!-- Pharmacokinetic data -->
'''Lamotrigin''' adalah [[Antikejang|obat antikonvulsan]] yang diindikasikan untuk mengatasi [[epilepsi]] danjuga [[gangguan bipolar]] . <ref name="AHFS2017">{{Cite web|title=Lamotrigine|url=https://www.drugs.com/monograph/lamotrigine.html|publisher=The American Society of Health-System Pharmacists|access-date=8 December 2017|archive-date=10 December 2017|archive-url=https://web.archive.org/web/20171210020403/https://www.drugs.com/monograph/lamotrigine.html|url-status=live}}</ref> Lamotrigin untuk penderita epilepsi, mengatasi kejadiankejang fokal, kejang tonik-klonik, dan juga obat ini mengatasi kejang pada sindrom Lennox-Gastaut . <ref name="AHFS2017">{{cite web|title=Lamotrigine|url=https://www.drugs.com/monograph/lamotrigine.html|publisher=The American Society of Health-System Pharmacists|access-date=8 December 2017|archive-date=10 December 2017|archive-url=https://web.archive.org/web/20171210020403/https://www.drugs.com/monograph/lamotrigine.html|url-status=live}}</ref> Untuk gangguan bipolar, lamotrigin digunakan untuk mengatasi depresi akut dan juga mengatasi [[Gangguan bipolar|siklus cepat]] pada [[Gangguan bipolar tipe II|bipolar tipe II]], lamotrigin juga bisa digunakan untuk pencegahan kekambuhan pada pasien [[Gangguan bipolar tipe I|bipolar tipe I.]] <ref name="AHFS2017">{{cite web|title=Lamotrigine|url=https://www.drugs.com/monograph/lamotrigine.html|publisher=The American Society of Health-System Pharmacists|access-date=8 December 2017|archive-date=10 December 2017|archive-url=https://web.archive.org/web/20171210020403/https://www.drugs.com/monograph/lamotrigine.html|url-status=live}}</ref>
| bioavailability = 98%
| protein_bound = 55%
| metabolism = [[Liver]] (mostly [[UGT1A4]]-mediated)
| metabolites =
| elimination_half-life= 29 hours
| excretion = [[Urine]] (65%), [[feces]] (2%)

<!-- Chemical and physical data -->
| C= 9 | Cl= 2 | H= 7 | N= 5
| SMILES = NC1=NC(N)=NN=C1C2=CC=CC(Cl)=C2Cl
| StdInChI = 1S/C9H7Cl2N5/c10-5-3-1-2-4(6(5)11)7-8(12)14-9(13)16-15-7/h1-3H,(H4,12,13,14,16)
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI_comment =
| StdInChIKey = PYZRQGJRPPTADH-UHFFFAOYSA-N
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| Jmol =
| molecular_weight = 256.091
| molecular_weight_unit= g/mol
| density =
| density_notes =
| melting_point =
| melting_high =
| melting_notes =
| boiling_point =
| boiling_notes =
| solubility =
| sol_units =
| specific_rotation =
}}

'''Lamotrigin''' adalah [[Antikejang|obat antikonvulsan]] yang diindikasikan untuk mengatasi [[epilepsi]] dan juga [[gangguan bipolar]] . <ref name="AHFS2017">{{Cite web|title=Lamotrigine|url=https://www.drugs.com/monograph/lamotrigine.html|publisher=The American Society of Health-System Pharmacists|access-date=8 December 2017|archive-date=10 December 2017|archive-url=https://web.archive.org/web/20171210020403/https://www.drugs.com/monograph/lamotrigine.html|url-status=live}}</ref> Lamotrigin untuk penderita epilepsi, mengatasi kejadian kejang fokal, kejang tonik-klonik, dan juga obat ini mengatasi kejang pada sindrom Lennox-Gastaut . <ref name="AHFS2017">{{cite web|title=Lamotrigine|url=https://www.drugs.com/monograph/lamotrigine.html|publisher=The American Society of Health-System Pharmacists|access-date=8 December 2017|archive-date=10 December 2017|archive-url=https://web.archive.org/web/20171210020403/https://www.drugs.com/monograph/lamotrigine.html|url-status=live}}</ref> Untuk gangguan bipolar, lamotrigin digunakan untuk mengatasi depresi akut dan juga mengatasi [[Gangguan bipolar|siklus cepat]] pada [[Gangguan bipolar tipe II|bipolar tipe II]], lamotrigin juga bisa digunakan untuk pencegahan kekambuhan pada pasien [[Gangguan bipolar tipe I|bipolar tipe I.]] <ref name="AHFS2017">{{cite web|title=Lamotrigine|url=https://www.drugs.com/monograph/lamotrigine.html|publisher=The American Society of Health-System Pharmacists|access-date=8 December 2017|archive-date=10 December 2017|archive-url=https://web.archive.org/web/20171210020403/https://www.drugs.com/monograph/lamotrigine.html|url-status=live}}</ref>

== Referensi ==
[[Kategori:Obat]]
[[Kategori:Obat]]
[[Kategori:Farmasi]]
[[Kategori:Farmasi]]

Revisi per 7 Februari 2024 04.42

Nama sistematis (IUPAC)
6-(2,3-dichlorophenyl)-1,2,4-triazine-3,5-diamine
Data klinis
Nama dagang Lamictal, others[1]
AHFS/Drugs.com monograph
MedlinePlus a695007
Data lisensi US Daily Med:pranala
Kat. kehamilan D(AU) C(US)
Status hukum Harus dengan resep dokter (S4) (AU) ℞-only (CA) POM (UK) ℞-only (US)
Rute By mouth
Data farmakokinetik
Bioavailabilitas 98%
Ikatan protein 55%
Metabolisme Liver (mostly UGT1A4-mediated)
Waktu paruh 29 hours
Ekskresi Urine (65%), feces (2%)
Pengenal
Kode ATC ?
Sinonim BW-430C; BW430C; 3,5-Diamino-6-(2,3-dichlorophenyl)-1,2,4-triazine
Data kimia
Rumus C9H7Cl2N5 
Massa mol. 256.091

  • InChI=1S/C9H7Cl2N5/c10-5-3-1-2-4(6(5)11)7-8(12)14-9(13)16-15-7/h1-3H,(H4,12,13,14,16) YaY
    Key:PYZRQGJRPPTADH-UHFFFAOYSA-N YaY

Lamotrigin adalah obat antikonvulsan yang diindikasikan untuk mengatasi epilepsi dan juga gangguan bipolar . [2] Lamotrigin untuk penderita epilepsi, mengatasi kejadian kejang fokal, kejang tonik-klonik, dan juga obat ini mengatasi kejang pada sindrom Lennox-Gastaut . [2] Untuk gangguan bipolar, lamotrigin digunakan untuk mengatasi depresi akut dan juga mengatasi siklus cepat pada bipolar tipe II, lamotrigin juga bisa digunakan untuk pencegahan kekambuhan pada pasien bipolar tipe I. [2]

Referensi

  1. ^ "Lamotrigine". Drugs.com. Diarsipkan dari versi asli tanggal 10 December 2017. Diakses tanggal 9 December 2017. 
  2. ^ a b c "Lamotrigine". The American Society of Health-System Pharmacists. Diarsipkan dari versi asli tanggal 10 December 2017. Diakses tanggal 8 December 2017.  Kesalahan pengutipan: Tanda <ref> tidak sah; nama "AHFS2017" didefinisikan berulang dengan isi berbeda
Diperoleh dari "https://wiki-indonesia.club/w/index.php?title=Lamotrigin&oldid=25276933"